title: Intestinal parasitosis among Yemeni patients with cancer, Sana'a, Yemen.
abstract: The profile of intestinal parasitosis was assessed among patients on anticancer chemotherapy in Sana'a city, Yemen during the period from April to December 2011. A total of 206 patients (115 males & 91 females), aged 3 to 18 years with mean of 14.17 +/- 3.13 were subjected to stool examinations by different techniques. The overall rate of intestinal parasites was 63.1%. Cryptosporidium parvum was the highest (30.1%) followed by G. lamblia (18.0%) and then C. cayetanensis (5.3%). Blastocystis hominis and E. histolytica/dispar were detected in 4.9% & 2.4% respectively. E. coli, H. nana and A. lumbricoides were diagnosed in an equal of 1.5% and S. stercoralis was seen in one case only. The majority of infected patients suffered from diarrhea. They showed 4.64 risk of protozoan infections compared to those who passed formed stool with statistically significant difference. Diarrhea was associated with higher risk of cryptosporidiosis and giardiasis (OR = 2.73 & 2.67 respectively). The risk of intestinal parasitosis neither differed significantly with patients' age nor sex.
authors.affiliation: Department of Medical Parasitology, Faculty of Medicine, and Health Sciences, Sana'a University, Sana'a, Yemen. salqobatis@yahoo.com
authors.forename: Salah A
authors.initials: SA
authors.lastname: Al-Qobati
authors.forename: Mohamed T
authors.initials: MT
authors.lastname: Al-Maktari
authors.forename: Abdulla M Bin
authors.initials: AM
authors.lastname: Al-Zoa
authors.forename: Mohamed
authors.initials: M
authors.lastname: Derhim
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005243:Feces / Q000469:parasitology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007411:Intestinal Diseases, Parasitic / Q000150:complications / Q000453:epidemiology* / Q000276:immunology; D008297:Male; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D015006:Yemen / Q000453:epidemiology
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents